U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. FDA/CDER and ASTM Workshop on Standard for Pharmaceutical Products, October 11, 2016
  1. News & Events for Human Drugs

FDA/CDER and ASTM Workshop on Standard for Pharmaceutical Products, October 11, 2016

This workshop is on Oct.11th. Committee meetings will be held on Oct. 12-13th.

Location:
FDA White Oak Campus. Silver Spring, MD

Goals and Objectives To provide a forum for open scientific discussions between FDA staff and ASTM committee members. This workshop will inform future participation in ASTM activities, which is a strategic priority of the Office of Policy for Pharmaceutical Quality (OPPQ).

  • Provide an opportunity for CDER staff to learn about ongoing standard development activities of ASTM E55.

Who Should Attend

This meeting and workshop is intended for a diverse group of scientists, responsible for manufacturing pharmaceutical products and evaluation of pharmaceutical quality.

The primary audience includes leading academic experts, interested pharmaceutical companies, scientists involved in drug development in those same industries, regulatory scientists, experts and leaders from industry and academia who use ASTM standards.

Contact
Pallavi Nithyanandan

Pallavi.Nithyanandan@fda.hhs.gov

Back to Top